Literature DB >> 6436437

Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia.

E Perdahl, R Adolfsson, I Alafuzoff, K A Albert, E J Nestler, P Greengard, B Winblad.   

Abstract

Synapsin I (Protein I), a neuron-specific phosphoprotein enriched in presynaptic nerve terminals, has been used as a quantitative marker for the density of nerve terminals in five brain regions (caudate nucleus, cingulate gyrus, hippocampus, mesencephalon and putamen) from patients who had suffered from Alzheimer disease/senile dementia of Alzheimer type (AD/SDAT), from patients with multi-infarct dementia (MID), and from age-matched controls. Samples were obtained at autopsy. Lower levels of Synapsin I were observed in the hippocampus of patients with AD/SDAT but not with MID. There were no significant differences in Synapsin I levels between patients and controls in any of the other four brain regions examined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436437     DOI: 10.1007/bf01245030

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  18 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Observations on the brains of demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1970-09       Impact factor: 3.181

Review 3.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

Review 4.  Protein phosphorylation in the brain.

Authors:  E J Nestler; P Greengard
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

5.  Presynaptic cholinergic dysfunction in patients with dementia.

Authors:  N R Sims; D M Bowen; S J Allen; C C Smith; D Neary; D J Thomas; A N Davison
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

6.  Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients.

Authors:  R Adolfsson; C G Gottfries; L Nyström; B Winblad
Journal:  Acta Psychiatr Scand       Date:  1981-03       Impact factor: 6.392

7.  Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study.

Authors:  M J Ball
Journal:  Acta Neuropathol       Date:  1977-02-28       Impact factor: 17.088

8.  Cellular and subcellular localization of protein I in the peripheral nervous system.

Authors:  G Fried; E J Nestler; P De Camilli; L Stjärne; L Olson; J M Lundberg; T Hökfelt; C C Ouimet; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

9.  Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems.

Authors:  G Bucht; R Adolfsson; B Winblad
Journal:  J Am Geriatr Soc       Date:  1984-07       Impact factor: 5.562

10.  Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections.

Authors:  P De Camilli; R Cameron; P Greengard
Journal:  J Cell Biol       Date:  1983-05       Impact factor: 10.539

View more
  10 in total

Review 1.  Synapse loss in dementias.

Authors:  Ryan Clare; Victoria G King; Martin Wirenfeldt; Harry V Vinters
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

Review 2.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

3.  Vascular dementia in Spatz-Lindenberg's disease (SLD): cortical synaptophysin immunoreactivity as compared with dementia of Alzheimer type and non-demented controls.

Authors:  S S Zhan; K Beyreuther; H P Schmitt
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.

Authors:  Katherine Garcia Ravelli; Barbara Dos Anjos Rosário; Rosana Camarini; Marina Sorrentino Hernandes; Luiz Roberto Britto
Journal:  Neurotox Res       Date:  2016-12-02       Impact factor: 3.911

5.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

Review 6.  [Synaptic vesicle proteins and psychiatric disorders].

Authors:  S Rapp; J Thome
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

7.  Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.

Authors:  Fang Du; Qing Yu; Shijun Yan; Zhihua Zhang; Jhansi Rani Vangavaragu; Doris Chen; Shi Fang Yan; Shirley ShiDu Yan
Journal:  Aging Cell       Date:  2021-05-05       Impact factor: 9.304

8.  Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability.

Authors:  Xinkun Wang; Mary L Michaelis; Elias K Michaelis
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

9.  Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.

Authors:  Kelly N Holohan; Debomoy K Lahiri; Bryan P Schneider; Tatiana Foroud; Andrew J Saykin
Journal:  Front Genet       Date:  2013-01-17       Impact factor: 4.599

10.  Habituation of Somatosensory Evoked Potentials in Patients with Alzheimer's Disease and Those with Vascular Dementia.

Authors:  Antonio Currà; Lucio Marinelli; Filippo Cotellessa; Laura Mori; Chiara Avanti; Daniela Greco; Manuela Gorini; Paolo Missori; Francesco Fattapposta; Carlo Trompetto
Journal:  Medicina (Kaunas)       Date:  2021-12-14       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.